08048035968

1. General Information

MYFORTIC 180 MG is an enteric-coated/delayed-release tablet containing mycophenolic acid (MPA) 180 mg as mycophenolate sodium. It suppresses certain immune-system responses that can cause the body to attack a transplanted organ.

It is mainly prescribed as part of an immunosuppressive regimen following kidney transplantation. The exact treatment regimen is determined by a transplant specialist.

2. Product Information

ProductMYFORTIC 180 MG Tablets
Active ingredientMycophenolic acid
Salt/formMycophenolate sodium
Strength180 mg
Dosage formDelayed-release/gastro-resistant tablet
Therapeutic classImmunosuppressant
Main indicationPrevention of organ rejection after kidney transplantation
RouteOral
Prescription statusPrescription medicine

The tablets are designed as a delayed-release formulation and should not be crushed, cut or chewed.

3. Uses of MYFORTIC 180 MG

MYFORTIC is primarily used to:

  • Help prevent kidney transplant rejection.
  • Suppress excessive immune-system activity after transplantation.
  • Maintain adequate immunosuppression as part of a transplant treatment regimen.
  • Be used alongside other prescribed immunosuppressive medicines.

The current U.S. prescribing information specifically indicates Myfortic for prevention of organ rejection in adult kidney-transplant recipients and certain pediatric kidney-transplant patients.

4. Benefits of This Medicine

When appropriately prescribed and monitored, MYFORTIC can:

  • Help reduce the risk of the immune system attacking a transplanted kidney.
  • Support long-term maintenance of the transplanted organ.
  • Provide a delayed-release formulation of mycophenolic acid.
  • Form part of a combination immunosuppressive treatment following transplantation.

It should not be viewed as a medicine that independently guarantees prevention of transplant rejection; treatment requires regular specialist monitoring.

5. Side Effects

Because MYFORTIC suppresses the immune system, it can cause significant adverse effects. Important risks include:

  • Increased susceptibility to bacterial, viral, fungal and other infections.
  • Reduced blood-cell counts, including anemia and leukopenia.
  • Gastrointestinal problems, including diarrhea, nausea and vomiting.
  • Increased risk of certain malignancies, particularly lymphoma and skin cancers.
  • Serious gastrointestinal complications such as ulcers, bleeding or perforation can occur.
  • Serious hypersensitivity reactions are possible.

6. Common Side Effects

Reported common adverse reactions include:

  • Anemia
  • Leukopenia
  • Constipation
  • Nausea
  • Diarrhea
  • Vomiting
  • Indigestion/dyspepsia
  • Urinary tract infection
  • CMV infection
  • Insomnia
  • Postoperative pain

Seek medical attention promptly for signs of serious infection, unusual bleeding, severe abdominal symptoms, difficulty breathing, or a severe allergic reaction.

7. How to Use

MYFORTIC should be taken exactly as prescribed by the transplant specialist.

For adult kidney-transplant patients, the U.S. prescribing information lists a usual recommended total dose of 720 mg twice daily, but individual treatment must be determined by the treating physician.

Important administration points:

  • Take the tablet orally.
  • Swallow the tablet whole.
  • Do not crush, chew or cut the tablet.
  • Follow the physician's instructions regarding food; the U.S. label recommends administration on an empty stomach, 1 hour before or 2 hours after food.
  • Do not change the dose or stop treatment without medical advice.
  • Take missed doses according to your healthcare professional's instructions.

8. How MYFORTIC Works

Myfortic contains mycophenolic acid, which inhibits an enzyme called inosine monophosphate dehydrogenase (IMPDH).

This reduces the production of certain substances required for the multiplication of lymphocytes. As a result, the activity of specific immune cells is reduced, helping decrease the immune response against the transplanted organ.

9. Safety Advice

Pregnancy: MYFORTIC can cause pregnancy loss and serious birth defects. Women who can become pregnant require appropriate pregnancy-prevention and planning measures under medical supervision.

Infections: Because immunity is suppressed, patients have a higher risk of infections. Report fever, sore throat, persistent cough or other signs of infection promptly.

Cancer risk: Long-term immunosuppression can increase the risk of lymphoma and other malignancies, including skin cancers. Appropriate sun protection is recommended.

Blood tests: Regular blood-count monitoring is important because MYFORTIC can cause anemia, leukopenia and other blood abnormalities.

Vaccination: Live attenuated vaccines should generally be avoided during treatment unless specifically advised by the treating specialist.

Drug interactions: Certain medicines, including some antacids, bile-acid sequestrants, sevelamer, azathioprine and others, can affect mycophenolic acid exposure or create interaction concerns. Always provide your doctor with a complete medication list.

Do not interchange formulations yourself: Myfortic delayed-release tablets and mycophenolate mofetil products are not automatically interchangeable because their absorption characteristics differ.

10. Frequently Asked Questions

Q1. What is MYFORTIC 180 MG used for?
It is an immunosuppressant primarily used to help prevent rejection of a transplanted kidney.

Q2. What is the active ingredient in MYFORTIC 180 MG?
It contains mycophenolic acid 180 mg, supplied as mycophenolate sodium.

Q3. Is MYFORTIC a prescription medicine?
Yes. It requires specialist medical supervision because of its significant immunosuppressive effects.

Q4. Can MYFORTIC be stopped suddenly?
Do not stop it without your transplant specialist's instructions because inadequate immunosuppression can increase the risk of transplant rejection.

Q5. Can MYFORTIC 180 MG tablets be crushed?
No. The delayed-release tablet should be swallowed whole and should not be crushed, chewed or cut.

Q6. Can MYFORTIC be taken during pregnancy?
Mycophenolic acid is associated with a substantial risk of pregnancy loss and congenital abnormalities. Pregnancy planning must be discussed with the treating specialist.

Q7. Does MYFORTIC increase infection risk?
Yes. Its immunosuppressive action increases susceptibility to infections, including opportunistic infections.

Q8. Can I replace MYFORTIC with another mycophenolate medicine?
Only under medical supervision. Different mycophenolate formulations are not necessarily interchangeable.

11. Substitute for MYFORTIC 180 MG

Potential alternatives containing mycophenolic acid/mycophenolate sodium 180 mg include brands such as:

  • Mycept-S 180 MG
  • Mofilet-S 180 MG
  • Renodapt-S 180 MG
  • Ceptimmun-S 180 MG
  • Other locally approved mycophenolate sodium 180 mg products

Availability varies by country and supplier.

Important: A substitute should not be selected solely on the basis of the same strength. The transplant physician should confirm the appropriate formulation and dose before any substitution.

12. SEO / B2B Keywords

For Phoenix Exim product marketing, relevant informational and B2B keywords include:

  • MYFORTIC 180 MG Tablets exporter from India
  • MYFORTIC 180 MG supplier India
  • MYFORTIC 180 MG tablets pharmaceutical exporter
  • MYFORTIC 180 MG wholesale supplier
  • MYFORTIC 180 MG tablets international supplier
  • Mycophenolic acid 180 mg tablets exporter
  • Mycophenolate sodium 180 mg supplier India
  • Mycophenolate sodium 180 mg tablets exporter
  • MYFORTIC 180 MG tablets supplier USA
  • MYFORTIC 180 MG tablets supplier UK
  • MYFORTIC 180 MG tablets supplier Australia
  • MYFORTIC 180 MG tablets supplier Singapore
  • MYFORTIC 180 MG tablets supplier Canada
  • MYFORTIC 180 MG tablets supplier South Korea
  • MYFORTIC 180 MG tablets supplier UAE
  • Kidney transplant immunosuppressant supplier
  • Mycophenolic acid tablets pharmaceutical supplier
  • Mycophenolate sodium tablets wholesale exporter
  • MYFORTIC 180 MG medicine exporter from Nagpur India
  • Trusted pharmaceutical exporter from India
  • Prescription medicine exporter India
  • Pharmaceutical products exporter Nagpur
  • MYFORTIC 180 MG bulk pharmaceutical supplier
  • Mycophenolate sodium 180 MG B2B supplier
  • MYFORTIC 180 MG international pharmaceutical supplier
Aug 19th, 2026 3:33 PM

Keywords